Pharmeo announced that it will issue 98,000 common shares at an issue price of KRW 101,100 per share for the gross proceeds of KRW 9,907,800,000 on February 15, 2023. The transaction will include participation from EOFLOW Co.,Ltd. for 98,000 shares. The transaction has been approved by the shareholders of the company and is expected to close on February 17, 2023.